Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.890
+0.130 (4.71%)
Mar 9, 2026, 4:00 PM EDT - Market closed

Cellectar Biosciences Market Cap

Cellectar Biosciences has a market cap or net worth of $12.25 million as of March 9, 2026. Its market cap has decreased by -20.43% in one year.

Market Cap
12.25M
Enterprise Value
-384.07K
1-Year Change
-20.43%
Ranking
Category
Stock Price
$2.89

Market Cap Chart

Since November 10, 2005, Cellectar Biosciences's market cap has increased from $7.50M to $12.25M, an increase of 63.39%. That is a compound annual growth rate of 2.44%.

History

DateMarket Cap% Change
Mar 6, 202611.70M-6.40%
Dec 31, 202512.50M1.63%
Dec 31, 202412.30M-63.82%
Dec 29, 202334.00M112.50%
Dec 30, 202216.00M-60.59%
Dec 31, 202140.60M-27.24%
Dec 31, 202055.80M164.45%
Dec 31, 201921.10M185.14%
Dec 31, 20187.40M-65.90%
Dec 29, 201721.70M233.85%
Dec 30, 20166.50M3.17%
Dec 31, 20156.30M-73.08%
Dec 31, 201423.40M9.86%
Dec 31, 201321.30M-37.72%
Dec 31, 201234.20M187.39%
Dec 30, 201111.90M325.00%
Dec 31, 20102.80M-98.80%
Dec 31, 2009233.20M2,164.08%
Dec 31, 200810.30M-56.90%
Dec 31, 200723.90M-22.90%
Dec 29, 200631.00M-30.49%
Dec 30, 200544.60M494.67%
View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
NewcelX 12.63M
BioCardia 12.52M
Phio Pharmaceuticals 12.49M
BioAtla 12.46M
CytoMed Therapeutics 12.12M
Soligenix 12.00M
Chemomab Therapeutics 11.57M
CalciMedica 11.45M
Market Cap Rankings